Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan Glicklich currently holds 10,000 shares of CHINOOK THERAPEUTICS, INC. (KDNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Glicklich has been a net seller of KDNY stock. They have purchased $0 and sold $357.5K worth of shares.
Alan Glicklich's most recent insider trade was on Aug 19, 2026, when they sold 10,000 shares at $0.00 per share.
Alan Glicklich serves as Executive at CHINOOK THERAPEUTICS, INC. (KDNY). They have executed 7 insider transactions totaling $357.5K over their tenure at the company.
Alan Glicklich holds the position of Executive at CHINOOK THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Alan Glicklich has shown a selling trading pattern, with $0 in total purchases and $357.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alan Glicklich was on Jun 16, 2021, when they sold $327.0K worth of KDNY shares. This transaction involved 20,000 shares at $16.35 per share.
Alan Glicklich currently owns 10,000 shares of CHINOOK THERAPEUTICS, INC. (KDNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan Glicklich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan Glicklich has 7 Form 4 filings on record as an insider at CHINOOK THERAPEUTICS, INC..
Set alerts for Alan Glicklich and 40,000+ other insiders.